These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30407867)

  • 21. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    McGinnes Cullen L; Schmidt MR; Morrison TG
    J Virol; 2019 May; 93(9):. PubMed ID: 30760576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections.
    Patel MC; Shirey KA; Boukhvalova MS; Vogel SN; Blanco JCG
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally.
    Watanabe W; Shimizu T; Sawamura R; Hino A; Konno K; Kurokawa M
    J Med Virol; 2010 May; 82(6):1075-82. PubMed ID: 20419825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.
    Russell RF; McDonald JU; Ivanova M; Zhong Z; Bukreyev A; Tregoning JS
    J Virol; 2015 Sep; 89(17):8974-81. PubMed ID: 26085154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophils in respiratory syncytial virus infection: A target for asthma prevention.
    Geerdink RJ; Pillay J; Meyaard L; Bont L
    J Allergy Clin Immunol; 2015 Oct; 136(4):838-47. PubMed ID: 26277597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease.
    Castilow EM; Meyerholz DK; Varga SM
    J Immunol; 2008 Feb; 180(4):2376-84. PubMed ID: 18250447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.
    Lee YN; Hwang HS; Kim MC; Lee YT; Lee JS; Moore ML; Kang SM
    Antiviral Res; 2015 Mar; 115():1-8. PubMed ID: 25513755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
    Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
    Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.
    Estripeaut D; Torres JP; Somers CS; Tagliabue C; Khokhar S; Bhoj VG; Grube SM; Wozniakowski A; Gomez AM; Ramilo O; Jafri HS; Mejias A
    J Infect Dis; 2008 Nov; 198(10):1435-43. PubMed ID: 18828742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.
    Haeberle HA; Kuziel WA; Dieterich HJ; Casola A; Gatalica Z; Garofalo RP
    J Virol; 2001 Jan; 75(2):878-90. PubMed ID: 11134301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
    Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O
    J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
    Hirose H; Matsuse H; Fukahori S; Tsuchida T; Tomari S; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int Arch Allergy Immunol; 2008; 147(3):197-205. PubMed ID: 18594149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses.
    Mebratu YA; Smith KR; Agga GE; Tesfaigzi Y
    Respir Res; 2016 Jul; 17(1):75. PubMed ID: 27363862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation.
    Rayavara K; Kurosky A; Stafford SJ; Garg NJ; Brasier AR; Garofalo RP; Hosakote YM
    J Immunol; 2018 Nov; 201(9):2753-2766. PubMed ID: 30275049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice.
    Remot A; Descamps D; Jouneau L; Laubreton D; Dubuquoy C; Bouet S; Lecardonnel J; Rebours E; Petit-Camurdan A; Riffault S
    Eur J Immunol; 2016 Apr; 46(4):874-84. PubMed ID: 26681580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal respiratory syncytial virus infection has an effect on lung inflammation and the CD4(+) CD25(+) T cell subpopulation during ovalbumin sensitization in adult mice.
    Comas-García A; López-Pacheco CP; García-Zepeda EA; Soldevila G; Ramos-Martínez P; Ramos-Castañeda J
    Clin Exp Immunol; 2016 Aug; 185(2):190-201. PubMed ID: 26990762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.